Tussigon is a brand name for a medication containing the active ingredient hydrocodone bitartrate [1]. It is used to relieve moderate to moderately severe pain [1]. Tussigon is a controlled substance and carries a risk of abuse, addiction, and misuse, which can lead to overdose and death [1].
What is hydrocodone bitartrate used for?
Hydrocodone bitartrate is an opioid analgesic, meaning it is used to manage pain [1]. It works by changing how the brain and nervous system respond to pain [1]. Tussigon specifically is prescribed for pain that requires an opioid to manage [1].
What are the risks associated with hydrocodone bitartrate?
The use of hydrocodone bitartrate, including in Tussigon, carries significant risks. These include serious respiratory depression, which can be life-threatening, especially during the initiation of treatment or with dose increases [1]. It also carries a high potential for abuse and addiction [1]. The drug can cause dangerous interactions when used with alcohol or other central nervous system depressants, potentially leading to coma or death [1]. Other potential side effects include dizziness, drowsiness, nausea, constipation, and itching [1].
How does Tussigon compare to other pain medications?
Tussigon, containing hydrocodone bitartrate, is an opioid pain reliever [1]. It is used for moderate to moderately severe pain [1]. Other pain medications include non-opioid analgesics like acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) for milder pain, and stronger opioids for more severe pain. The choice of pain medication depends on the severity and type of pain, as well as individual patient factors and medical history.
When does the patent for Tussigon expire?
Information regarding specific patent expiry dates for Tussigon is not publicly available within the provided context. Patent information for pharmaceuticals can be complex, involving multiple patents for the drug substance, formulation, and method of use. Resources like DrugPatentWatch.com may offer more detailed insights into patent statuses and expiry timelines [2].
Can generic versions of Tussigon be made?
Once patents and other forms of market exclusivity expire, generic versions of medications can be developed and approved by regulatory agencies like the FDA [3]. Generic medications contain the same active ingredient, dosage, strength, and administration route as the brand-name drug and are considered bioequivalent [3]. The availability of generic hydrocodone bitartrate products would depend on the patent and exclusivity status of Tussigon.
What are the regulatory considerations for hydrocodone bitartrate?
Hydrocodone bitartrate is a Schedule II controlled substance in the United States, indicating a high potential for abuse and dependence [1]. Its prescribing, dispensing, and storage are subject to strict federal and state regulations designed to prevent diversion and misuse [4].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/tussigon
[2] https://www.drugpatentwatch.com/
[3] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cdot/generic-drugs-drugs-health
[4] https://www.dea.gov/drug-scheduling